December 25, 2014 3:09 PM ET

Capital Markets

Company Overview of Colony Capital, LLC

Executive Profile

Richard D. Nanula

Former Chief Financial Officer, Executive Vice President of Finance and Executive Vice President of Strategy & Communications, Amgen Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 8 different industries.

See Board Relationships
53--

Background

Mr. Richard D. Nanula was a Principal at Colony Capital, LLC. Mr. Nanula joined Colony Capital on January 8, 2008. He served as an Executive Vice President of Finance, Strategy, & Communications at Amgen Inc. and served as its Chief Financial Officer from August 2001 to April 2007. He joined Amgen in 2001. From November 1999 to February 2001, he served as the Chairman and Chief Executive Officer at BroadBand Sports, Inc. From March 1998 to May 1999, he served as the ...

Corporate Headquarters

2450 Broadway
Santa Monica, California 90404

United States

Phone: 310-282-8820
Fax: 310-282-8808

Board Members Memberships

Director
Chairman
Trustee
Chairman
Former Board Member
Director
1999-N/A
Former Chairman of the Board and Chief Executive Officer
2005-2007
Former Independent Director, Member of Audit Committee, Member of Special Programs Committee and Member of Finance Committee

Education

MBA 1986
Harvard University
BA 1982
University of California, Santa Barbara

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.3M
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
$15.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Colony Capital, LLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.